MI-ONESTREAM-SOFTWARE
29.3.2021 12:02:05 CEST | Business Wire | Press release
OneStream Software , a leading provider of modern corporate performance management (CPM) solutions for mid-sized to large enterprises, has been recognized as a market leader in the Business Application Research Center’s (BARC) global report on financial performance management software solutions. The BARC Score Financial Performance Management Global 2021 report places OneStream as a market leader with among the highest Portfolio Capabilities scores across vendors.
After hiring more than 270 employees throughout 2020, the company exceeded its 2020 projections and achieved 85 percent growth in Annual Recurring Revenue (ARR), accumulating more than 650 customers and achieving triple digit ARR CAGR in the EMEA region from 2017-2020. OneStream closed the year with 690 employees across 15 countries and more than 200 partners worldwide including PWC, Accenture and other general advisory firms. OneStream will continue to expand its workforce and partner ecosystem in 2021, including its opening of an Asia-Pacific (APAC) headquarters in Sydney, Australia.
“For OneStream to be recognized as a market leader in only the second year of coverage in the BARC Score report for Financial Performance Management solutions for global vendors reflects the broad capabilities of the platform and strong market adoption for global organizations worldwide. OneStream’s growth trajectory and commitment to 100% customer success positions the company to continue to challenge more established vendors as a leader in this market,” said Dr. Christian Fuchs, Senior Vice-President and Head of Data & Analytics Research at BARC.
The BARC Score report noted OneStream’s unified CPM platform for financial consolidation, close reporting and planning with built-in financial analytic engine and financial data quality capabilities as a strength, along with integrated analysis and reporting functionality. BARC also identified the OneStream MarketPlace, which hosts more than 50 downloadable business and productivity solutions optimized for the platform, as another strength. Overall, the report cited OneStream as having “excellent customer feedback for many important KPIs in BARC’s Planning Survey.”
“We are proud to be recognized in the BARC Score Financial Performance Management Global report as a market leader,” said Ricardo Rasche, Senior Vice President of International Sales for OneStream Software. “The BARC Score validates our underlying commitment to delivering 100% customer success for global organizations based in Germany, Austria, Switzerland and across the world. We are honored by this distinction as a market leader among much more established legacy vendors in EMEA.”
Last year in BARC’s The Planning Survey 20 , OneStream earned 38 top ranks and a 97% customer recommendation score. The BARC Score Financial Performance Management Global report examines global vendors, evaluating different criteria on two axes, “Portfolio Capabilities” and “Market Execution.” Vendors evaluated generated more than 20 million EUR in license revenue per year with its product set across EMEA, North America, Latin America and/or Asia-Pacific.
OneStream is helping a growing list of companies worldwide digitally transform finance and support strategic business decisions across the enterprise. OneStream customers are able to replace multiple legacy applications with OneStream’s unified Intelligent Finance platform and streamline key finance processes. Valued at more than $1B in 2019 and backed by global investment firm KKR, OneStream recently announced 2020 results and is well poised for a strong 2021.
To download the full report, click here .
About OneStream Software
OneStream Software provides a market-leading intelligent finance platform that reduces the complexity of financial operations. OneStream unleashes the power of finance by unifying corporate performance management (CPM) processes such as planning, financial close & consolidation, reporting and analytics through a single, extensible solution. We empower the enterprise with financial and operational insights to support faster and more informed decision-making. All in a cloud platform designed to continually evolve and scale with your organization.
OneStream is an independent software company backed by private equity investor KKR. With over 600 customers, 200 partners and over 700 employees our primary mission is to deliver 100% customer success. To learn more visit www.onestreamsoftware.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210329005071/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom